Comparison of the effect of a hyaluronate–trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to severe dry eye disease
- 7 February 2018
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 34 (8) , 1373-1376
Abstract
To describe a post hoc analysis comparing the effect of a hyaluronic acid (HA)-trehalose solution to an established eyedrop solution containing HA alone using Ocular Surface Disease Index (OSDI) score <19 as a threshold for moderate to severe dry eye disease (DED). A phase III, randomized, controlled, single-blind, multicenter study was conducted in France and Tunisia to evaluate the efficacy and safety of HA-trehalose (N = 52) and HA (N = 53) administered for 84 days. Eligible patients had moderate to severe DED with OSDI ≥18. Here the results of a post hoc analysis of the percentage of patients with OSDI <19 on Day 35 and Day 84 are reported. Significantly more patients had OSDI <19 at Day 84 in the HA-trehalose group than in the HA group (78.8% versus 58.5%; p = .025). At Day 35, more patients had OSDI <19 in the HA-trehalose group than in the HA group, but this difference was not statistically significant. Furthermore, approximately twice as many patients in the HA group (41.5%) still had OSDI 19-100 at Day 84 compared to the HA-trehalose group (21.2%). This data supports the addition of trehalose to HA-containing eyedrop solutions to provide better symptomatic relief from moderate to severe DED, based on an OSDI score of <19 after 84 days of treatment.Keywords
This publication has 9 references indexed in Scilit:
- A Randomized, Controlled Study of the Efficacy and Safety of a New Eyedrop Formulation for Moderate to Severe Dry Eye SyndromeEuropean Journal of Ophthalmology, 2016
- Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group MeetingThe Ocular Surface, 2013
- A review of hyaluronan and its ophthalmic applicationsOptometry - Journal of the American Optometric Association, 2011
- Minimal Clinically Important Difference for the Ocular Surface Disease IndexArchives of Ophthalmology (1950), 2010
- Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosisExperimental Eye Research, 2009
- Management and Therapy of Dry Eye Disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)The Ocular Surface, 2007
- Trehalose protects corneal epithelial cells from death by dryingBritish Journal of Ophthalmology, 2001
- The Pathology of Dry EyeSurvey of Ophthalmology, 2001
- Reliability and Validity of the Ocular Surface Disease IndexArchives of Ophthalmology (1950), 2000